Arash Esmaeili

Artificial intelligence-driven biomarker discovery and response prediction in cancer immunotherapy: a pan-cancer perspective

Cancer immunotherapy has transformed medical oncology, while individual’s therapeutic response to treatment is difficult because of the diverse nature and features of tumors and low precision and accuracy of markers, such as PD-L1, Tumor Mutational Burden (TMB), and Microsatellit...